title: Long-term follow-up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia.
authors.affiliation: Princess Margaret Cancer Centre/Ontario Cancer Institute, Toronto, ON, Canada. christine.chen@uhn.ca.
authors.forename: Christine I
authors.initials: CI
authors.lastname: Chen
authors.forename: Harminder
authors.initials: H
authors.lastname: Paul
authors.forename: Trina
authors.initials: T
authors.lastname: Wang
authors.forename: Lisa W
authors.initials: LW
authors.lastname: Le
authors.forename: Nimisha
authors.initials: N
authors.lastname: Dave
authors.forename: Vishal
authors.initials: V
authors.lastname: Kukreti
authors.forename: Ellen
authors.initials: E
authors.lastname: Nong Wei
authors.forename: Anthea
authors.initials: A
authors.lastname: Lau
authors.forename: Peter Leif
authors.initials: PL
authors.lastname: Bergsagel
authors.forename: Suzanne
authors.initials: S
authors.lastname: Trudel
mesh_terms: D000328:Adult; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide; D000077269:Lenalidomide
keywords: IMiDs; chronic lymphocytic leukaemia; therapy